While important clinical advances have been made in the care of patients with common malignancies, such as breast cancer, the treatment of soft tissue sarcomas has remained largely unchanged for over three decades. This lack of progress is due in part to the histological heterogeneity of human soft tissue sarcomas and the relative paucity of genomic and other analyses performed to date. Most patients with soft tissue sarcomas present with an isolated mass in the limbs, but approximately one-third will develop lung metastases and die from their disease. Because no molecular features are known to reliably predict for the development of lung metastasis, there are no molecular markers available to guide the selection of patients for systemic therapy. We hypothesize that the key molecular mechanisms of lung metastasis from soft tissue sarcomas will be conserved across vertebrate species. The goal of this proposal is to use cross- species systems genetics with human and mouse soft tissue sarcomas to identify mechanisms of lung metastasis. We will perform a comprehensive genomic analysis of mouse soft tissue sarcomas at the DNA and RNA level and use sophisticated computational analysis to compare these data to similar genomic studies from human sarcomas. We anticipate that this comparative systems genetic approach will identify molecular correlates of lung metastasis and will also reveal important mechanisms of lung metastasis. These studies will identify genomic signatures of metastasis that can be used to select individual patients with soft tissue sarcomas for systemic therapy. Moreover, new insights into mechanisms of lung metastasis may identify novel molecular targets for cancer therapy.

Public Health Relevance

Project Narrative Although important advances have been made in the treatment of patients with common epithelial cancers, such as breast cancer, patients with soft tissue sarcomas have largely not benefited from the application of cancer genomics. The overall goal of this proposal is to utilize cross-species genomic analyses to identify mechanisms of lung metastasis from soft tissue sarcomas. We will perform genomic studies on sarcomas from a mouse model to identify signatures that correlate with lung metastases. Using systems genetics, we will compare the mouse genomic data with genomic studies that have been carried out on human sarcomas by our collaborators. We will validate the metastasis signatures in independent cohorts of mouse and human sarcomas. We will also generate transgenic mice to determine the mechanisms by which these genetic changes contribute to metastasis. These studies will identify genomic signatures of metastasis in human tumors that may be used to select individual patients with soft tissue sarcomas for systemic therapy. Moreover, new insights into mechanisms of lung metastasis may identify novel molecular targets for sarcoma therapy.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA138265-05
Application #
8305064
Study Section
Special Emphasis Panel (ZCA1-GRB-I (O3))
Program Officer
Jhappan, Chamelli
Project Start
2008-09-25
Project End
2013-07-31
Budget Start
2012-08-01
Budget End
2013-07-31
Support Year
5
Fiscal Year
2012
Total Cost
$427,883
Indirect Cost
$153,599
Name
Duke University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Sachdeva, Mohit; Mito, Jeffrey K; Lee, Chang-Lung et al. (2014) MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes. J Clin Invest 124:4305-19
Schönhuber, Nina; Seidler, Barbara; Schuck, Kathleen et al. (2014) A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer. Nat Med 20:1340-7
Li, Zhizhong; Zhang, Yunyu; Ramanujan, Krishnan et al. (2013) Oncogenic NRAS, required for pathogenesis of embryonic rhabdomyosarcoma, relies upon the HMGA2-IGF2BP2 pathway. Cancer Res 73:3041-50
Mito, Jeffrey K; Min, Hooney D; Ma, Yan et al. (2013) Oncogene-dependent control of miRNA biogenesis and metastatic progression in a model of undifferentiated pleomorphic sarcoma. J Pathol 229:132-40
Eisinger-Mathason, T S Karin; Zhang, Minsi; Qiu, Qiong et al. (2013) Hypoxia-dependent modification of collagen networks promotes sarcoma metastasis. Cancer Discov 3:1190-205
Blum, Jordan M; Ano, Leonor; Li, Zhizhong et al. (2013) Distinct and overlapping sarcoma subtypes initiated from muscle stem and progenitor cells. Cell Rep 5:933-40
Lee, Chang-Lung; Moding, Everett J; Huang, Xiaofang et al. (2012) Generation of primary tumors with Flp recombinase in FRT-flanked p53 mice. Dis Model Mech 5:397-402
Kirsch, David G (2011) Using genetically engineered mice for radiation research. Radiat Res 176:275-9
Dodd, Rebecca D; Mito, Jeffery K; Kirsch, David G (2010) Animal models of soft-tissue sarcoma. Dis Model Mech 3:557-66
Mito, Jeffrey K; Riedel, Richard F; Dodd, Leslie et al. (2009) Cross species genomic analysis identifies a mouse model as undifferentiated pleomorphic sarcoma/malignant fibrous histiocytoma. PLoS One 4:e8075